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Early glomerular dysfunction in human renal allografts. In the last two decades, major advances in immunosup-
Background. The long-term outcome of renal allografts is pressive management have resulted in excellent (90%)
characterized by a progressive deterioration of renal function one-year survival of kidney transplants [1]. Despite thisand graft loss. Our aim was to determine early glomerular func-
success in early graft survival, the long-term outcome oftional abnormalities, before they become clinically apparent.
renal transplantation is characterized by renal dysfunc-Methods. Glomerular hemodynamics and dextran sieving
were characterized in 21 well-functioning cadaveric renal allo- tion and graft loss. At ten years post-transplantation only
graft recipients [normal glomerular filtration rate (GFR) and about 50% of cadaveric grafts are still functioning and
albumin excretion rate (AER), who also had a kidney biopsy most of them have evidence of damage as assessed bywith normal or minimal histological changes] and in 15 unin-
a high serum creatinine [2, 3]. Histologically, the termephrectomized kidney donors. Both groups were one to three
chronic transplant nephropathy has been coined to char-years after transplantation or uninephrectomy.
Results. The GFR and renal plasma flow (RPF) were similar acterize this loss of kidney function and is characterized
in both groups (62  3 vs. 63  4, and 343  26 vs. 334  by a combination of vascular, glomerular and tubulo-
21 mL/min/1.73 m2 for GFR and RPF, in cadaveric recipients
interstitial changes [4]. The reasons for chronic trans-vs. donors, respectively), the AER was normal in both groups,
plant nephropathy and graft loss are probably multifacto-but the mean arterial pressure was higher in renal recipients
(103  3 vs. 94  3 mm Hg in uninephrectomy controls, P  rial and include immunological mechanisms related to
0.05). Despite similar levels of overall glomerular function in allorecognition [5, 6], pre-existing renal allograft damage
the two groups, the dextran sieving curve was uniformly ele- or induced by ischemia at the time of transplantation
vated in the renal allograft recipients versus uninephrectomy
[7, 8], drug nephrotoxicity [9], and long-term effects ofcontrols (P 0.05 for dextrans 38 to 66 A˚). Using a log-normal
hypertension [10]. Recurrent disease [11] or de novoglomerular pore-size distribution model to analyze potential
mechanisms, the elevation in the dextran sieving curve resulted glomerulopathies [12] also may affect renal allografts
from a shift in the distribution of glomerular filtering pores to and contribute to graft loss.
a larger size (mean glomerular pore size 46  2 vs. 43  2 A˚ The clinical manifestations of chronic transplant ne-for uninephrectomy controls, P  0.05), resulting in a larger
phropathy include proteinuria, indicating a loss of glo-fraction of filtrate volume permeating very large pores. By
merular permselectivity, and progressive renal insuffi-morphometric analysis, the thickness of the glomerular base-
ment membrane was increased in kidney allograft as compared ciency [6]. Pathophysiologically, we and others have
to 2-kidney biopsy controls (614  33 vs. 427 22 nm, respec- found that in chronic transplant nephropathy there is
tively, P  0.05). functional damage to the glomerulus with high excretionConclusions. Even in “well functioning” renal allografts
rates of albumin and IgG, resulting from a loss of glomer-there is a glomerular dysfunction characterized by increased
ular charge and size-selectivity, and a reduced glomeru-permeability to macromolecules resulting from a shift of the
glomerular pores to a larger size. These changes could be medi- lar ultrafiltration coefficient [13], all features of glomeru-
ated by ultrastructural alterations at the glomerular capillary lar capillary wall injury.
or by alterations in intraglomerular hemodynamics. Early allo-
In healthy humans, the removal of 50% of kidney massgraft dysfunction may contribute to the progressive renal insuf-
by nephrectomy results in a rapid increase in glomerularficiency of renal allografts.
filtration rate (GFR) and renal plasma flow (RPF), along
with hypertrophy of the remnant kidney, thought to rep-
resent an adaptation to increased metabolic demands
[14]. In humans, these changes occur after kidney dona-
tion. As early as one week after uninephrectomy, theKey words: dextran sieving, permselectivity, uninephrectomy, glomer-
ular morphometry, transplantation, hemodynamics. GFR and RPF increase by 20 to 25% and after six months
are 20 to 37% higher [15, 16]. Similar adaptative changesReceived for publication October 30, 2000
occur in the transplanted kidney [17]. In contrast to theand in revised form May 24, 2001
Accepted for publication May 31, 2001 transplanted renal allograft, the long-term outcome of a
solitary kidney as a result of kidney donation or after 2001 by the International Society of Nephrology
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uninephrectomy related to trauma has been reported to and 8 female, and 18 were Caucasian and 3 African
American.be excellent in humans, with no significant increase in
A kidney biopsy had been performed in all patientsthe prevalence of late proteinuria or renal insufficiency
within four weeks of the renal function determination[18, 19], and only a slight increase in the prevalence of
as part of a protocol evaluating the use of mycophenolatehypertension [20].
mofetil or a humanized anti T-cell antibody versus con-Long-term studies have demonstrated that at 20 years
ventional triple immunosuppression in renal transplanta-post-transplantation only about 15 to 20% of renal trans-
tion. None of the biopsies had changes of acute rejection,plant patients survive with a functioning graft [21]. This
chronic transplant glomerulopathy or pathological fea-suggests that most renal allografts, irrespective of their
tures of cyclosporine toxicity. The histological findingsfunctional status at one year, could be at risk for late
were “mild interstitial fibrosis and tubular atrophy” inrenal failure. Our present study sought to determine if
9 cases, “mild nonspecific changes” in 8, and normalthere are abnormalities in glomerular hemodynamics
in 4 cases. There were no statistical differences in theand glomerular capillary wall function in clinically “nor-
measured physiological parameters (see below) betweenmal” cadaveric renal allografts one to three years after
patients with a normal biopsy and those with mild inter-transplantation by comparing them to those of single
stitial fibrosis, and, thus, they were grouped together forkidney individuals who had donated a kidney for trans-
analysis.plantation one to three years earlier. Our goal was to
Control population. Sixteen kidney donors who hadidentify early abnormalities in glomerular function, be-
donated a kidney in the previous one to three years werefore they are manifested clinically, to provide insight
contacted to have their glomerular function evaluated.into mechanisms contributing to progressive renal insuf-
After renal function determination, one of the donorsficiency in renal allografts. We also performed a morpho-
was found to have significant proteinuria (AER of 1440metric analysis of renal allograft biopsies to determine
g/min) that had not been present at the time of kidneyif there are ultrastructural alterations associated with
donation. This patient’s proteinuria was subsequentlyabnormalities in glomerular function.
determined to be related to hepatitis B contracted some-
time after kidney donation, and this patient was excluded
METHODS from the analysis. Thus, 15 healthy donor individuals (7
males, 8 females; 14 Caucasian, 1 Hispanic) were studied.Study population
Their median age at the time of renal function determi-
Cadaveric renal allograft recipients. Twenty-one indi-
nation was 49 years (range 29 to 71), and they were not
viduals were identified (12 males, 9 females) who were taking medications. Both patients and control subjects
more than one-year post-transplantation with normal consented to a study that had previously been approved
renal function [defined as a GFR 40 mL/min 1.73 m2 by the Human Investigations Committee of Emory Uni-
and albumin excretion rate (AER) 25 g/min]. Their versity. Finally, control renal biopsies were obtained
median age was 51 years (range 21 to 72) and the mean from kidneys of 16 cadaveric donors (9 male, 7 female)
time since transplantation was two years (range 1 to 3). at the time of transplantation, after the establishment of
The immunosuppression consisted of prednisone, cyclo- the vascular anastomosis. Their median age was 39 years
sporine A (CsA) and either azathioprine (N  8) or (range 15 to 57); 13 were Caucasian, 2 African American
mycophenolate mofetil (N  13). Five patients had had and 1 Hispanic. At the time of procurement, their mean
a rejection episode at two weeks to three months after serum creatinine was 1.2  0.1 mg/dL (range 0.3 to 1.8).
transplantation, which responded to a pulse of methyl- Because of ethical reasons, kidney biopsies were not
prednisolone (4 patients) or OKT3 (1 patient). At the obtained in the single kidney kidney donors who had
time of the renal function evaluation, the maintenance volunteered for renal function evaluation.
dose of prednisone was 10 mg/day, and the 12-hour whole
Glomerular function studiesblood trough cyclosporine level was 199  17 ng/mL.
Eighteen of the 21 patients were receiving antihyperten- A differential solute clearance technique was used to
sive drugs: dihydropyridine calcium channel blockers (7), measure glomerular function as described [22]. The
angiotensin-converting enzyme (ACE) inhibitors (5), or morning dose of cyclosporine was held until the comple-
both (5); one patient was taking a loop diuretic. Of the tion of renal function determination, to avoid acute
patients on ACE inhibitors, the majority (7) was on low- changes in renal hemodynamics. Briefly, an intravenous
dose enalapril (2.5 to 5 mg/day), and three patients were catheter was inserted in each arm to infuse clearance
on a dose of enalapril or equivalent of 7.5 to 20 mg/ markers and to collect blood. After a baseline blood
day. Cadaveric donor information was obtained from sample, diuresis was initiated with a 10 mL/kg water
the Transplant Registry. The median age of the cadaveric load, and maintained by drinking an equivalent volume
of water to that of voided urine. Intravenous loadingdonors was 19 years (range 13 to 49), 13 were male
Zayas and Guasch: Glomerular function in renal transplantation1940
doses of inulin, para-aminohippuric (PAH) acid and dex- The glomerular hemodynamic and dextran sieving
tran 40 were administered, followed by an intravenous data were analyzed according to a continuous pore-size
infusion to maintain target levels [22]. After a 40-minute distribution model of the glomerular capillary wall, fol-
equilibration period, four urine collections of 30 minutes lowing a log-normal probability distribution [31]. Ac-
duration were obtained after spontaneous voiding, with cording to this model, the distribution of pore sizes is
blood samples taken at the beginning and end of each characterized by two parameters: the mean pore radius
urine collection. GFR was calculated as the average of (u), and the standard deviation of the distribution (s).
the four inulin clearances, and the RPF as the average Two additional derived parameters (r*5%, and r*1%),
of the clearances of PAH, adjusted for a tubular extrac- which relate to the pore size permeating 5% and 1% of
tion of 85% [23]. The filtration fraction was calculated the total filtrate volume, respectively, provide a quantita-
as the ratio between GFR and RPF. tive estimate of the prominence of the very large pores
The concentrations of inulin and PAH were measured of the distribution [32]. The log-normal model provided
as described [24]. Plasma albumin and IgG concentra- a better fit of the dextran sieving data in these non-
tions were measured by a turbidometric technique using proteinuric individuals than the isoporous plus shunt
specific antibodies, and, in urine, by radioimmunoassay model, and therefore, it was used for the analysis.
(RIA) and enzyme-linked immunosorbent assay (ELISA),
Morphometric analysisrespectively, as reported [24]. Plasma oncotic pressure
was measured by membrane osmometry and used as the Tissue from patients and control biopsies was pro-
arteriolar oncotic pressure [24]. Dextran in urine and cessed for morphometric analysis. Kidney biopsy tissue
plasma was separated by size-exclusion chromatography, from renal allograft recipients (3 cores, on average) was
using precalibrated Sephacryl HR-300 columns (Phar- obtained percutaneously using an automated spring-
macia Fine Chemicals, Uppsala, Sweden) and measured loaded biopsy needle (Bard Monopty Biopsy Instru-
by the anthrone method [25]. Fractional dextran clear- ment, Covington, GA, USA). Control kidney tissue was
ances were calculated by dividing the clearance of each obtained by a wedge open technique after the establish-
macromolecule by that of inulin. ment of the vascular anastomosis of the renal allograft.
The rate of glomerular filtration is determined by the Otherwise, the tissue was processed in both patients and
relationship between ultrafiltration coefficient and net controls in an identical fashion. Briefly, tissue for light
ultrafiltration pressure according to: microscopic examination was fixed in 10% neutral buf-
fered formalin, dehydrated through graded alcohols,GFR  Kf  PUF  Kf  [P  	] (Eq. 1)
cleared and infiltrated and embedded in paraffin. Sec-
where Kf is the two-kidney ultrafiltration coefficient and tions approximately 3 thick were stained with hematox-
PUF is the net ultrafiltration pressure (the difference be- ylin and eosin, periodic acid-Schiff reagent and Masson
tween the transglomerular capillary hydrostatic pressure trichrome. On average, 17 glomeruli (range 7 to 44)
(P) and mean glomerular oncotic pressure, 	). In
were analyzed for each patient. The average number of
turn,
glomeruli analyzed in the 16 biopsies from control sub-
Kf  S  k (Eq. 2) jects was 32 (range 12 to 81). A computer system con-
sisting of an Olympus microscope, video camera, dedi-where S is the total capillary surface available for filtra-
cated computer, a digitizing tablet and imaging analysistion and k is the intrinsic hydraulic membrane conduc-
software (Bioquant; R&M Biometrics, Inc., Nashville,tivity.
TN, USA) was used to perform the measurements. AtA mathematical model for the filtration of water was
the light microscopic level, the number of open, segmen-used to compute Kf from values of GFR, RPF, 
A and
tally sclerosed, and occluded glomeruli were recorded.P [26]. Three of these variables (GFR, RPF and 
A)
The glomerular tuft cross-sectional area (AG) was mea-were measured; the fourth, P, cannot be measured in
sured by tracing the outline of the glomerular profilehumans. Based on micropuncture in animal studies
onto a digitizing tablet at900 magnification. Glomeru-[27, 28], and indirect evidence from studies of adult hu-
lar volume (VG) was calculated from the glomerular tuftmans [29, 30] a physiologic range for P in humans has
planar area as:been estimated between 35 and 40 mm Hg. Thus, we
computed Kf at a P of 40 mm Hg in all patients and con-
VG 
b
K
 (AG)3/2 (Eq. 3)trols. Moreover, since transplant recipients had higher
systemic mean arterial pressure values than their unin-
where b and K are factors that correct for angle of sec-ephrectomized counterparts, which could be transmitted
tioning and spherical shape [33]. The percentage of glo-to the glomerular capillaries, we also computed mem-
merular sclerosis was calculated from the light micro-brane parameters in transplant recipients at a P of 45
mm Hg. scopic measurements, adjusted for the probability of
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encountering sclerosed glomeruli in a random section were selected for the study. Both renal transplant recipi-
ents and uninephrectomy controls had a similar age and[23]:
gender distribution (Table 1). The time after transplanta-
tion was slightly longer, on average, in the renal recipi-G1 
F1
F1  (1  F1)(D1/D2)
(Eq. 4)
ents than in uninephrectomized donors (2.4  0.2 vs
1.3 0.2 years, respectively, P 0.05). The serum creati-where G1 is the true fraction of sclerosed glomeruli,
nine (SCr) values were within the normal range (1.2 and F1 is the observed fraction of sclerosed glomeruli;
0.1 mg/dL) and identical in the uninephrectomy groupD1 and D2 are the respective mean diameters of occluded
and in the renal transplant group, despite a reduced GFRand open glomeruli calculated from VG.
(see below). Body weight was slightly lower in cadavericThe fraction of cortical interstitial volume was calcu-
renal recipients than in uninephrectomized donors, butlated superimposing a calibrated grid and performing
both groups had similar BMI (Table 1). The mean dailypoint counting.
cyclosporine A dose in the renal allograft recipients wasTissue was prepared for electron microscopy using
4.5  0.5 mg/kg, and the mean 12-hour trough wholestandard techniques. In brief, tissue was cut into 1 mm
blood cyclosporine level was 199  17 ng/mL.cubes, fixed in 4% buffered glutaraldehyde, post-fixed
Despite antihypertensive medication taken by 18 ofin 1% osmium tetroxide, dehydrated through graded
21 renal allograft recipients, their mean arterial pressurealcohols, propylene fixed, and infiltrated and embedded
(MAP) was significantly higher than in uninephrectomyin epoxy resin. Polymerized blocks were sectioned at ap-
controls (103  3 vs. 94  3 mm Hg, respectively, P proximately 0.5 micrometers and toluidine blue-stained
0.05). The GFR and RPF were similar in the renal allo-sections were used to locate two open glomeruli closest
graft recipients and in renal donors when corrected forto the center of the section. Ultrathin sections (80 nm
body surface area (Table 2), or when expressed as abso-thick) were stained with lead citrate and photographed.
lute values: 67  4 versus 70  4 mL/min, and 376  28Photomontages of two open glomeruli (3430) were
versus 362 32 mL/min for GFR and RPF, in transplantprepared. The density of the peripheral capillary filtering
recipients versus kidney donor controls, respectively.surface (Sv), the volume densities of the glomerular cap-
Consequently, the ratio between GFR and RPF (filtra-illaries (VvCap) and mesangium (VvM), and the glomerular
tion fraction, FF) was identical in both groups. There werecapillary length density (LvCap) and average glomerular
no differences in the serum albumin and IgG concentra-capillary diameter were calculated by point counting us-
tions (data not shown), plasma oncotic pressure or the ex-ing stereological techniques [23, 34]. The peripheral cap-
cretion rates of albumin and IgG between renal allograftillary surface area (S) was calculated as the product of
recipients and uninephrectomy controls (Table 2).Sv and the volume of the open glomeruli (VG) deter-
Despite almost identical overall glomerular functionmined by light microscopy. Eight to ten high-powered
in the two groups, there were striking differences be-micrographs (13,320) of each glomerulus were used to
tween the groups in glomerular permeability as detectedmeasure glomerular basement membrane thickness and
by dextran sieving analysis. As shown in Figure 1, aepithelial filtration slit frequency. The thickness of the
generalized increase in sieving curve was present in theperipheral capillary basement membrane (BMT) was
renal allograft group, and the fractional permeability formeasured as the harmonic mean, using an orthogonal
discrete dextran molecules was statistically significant forinterception method. On average, 162 determinations of
all dextrans larger than 36 A˚ (38 to 66 A˚, P  0.05).basement membrane thickness were made per patient.
To calculate the intrinsic functional parameters of theThe frequency of the epithelial filtration slits was calcu-
glomerular capillary, we modeled the dextran sievinglated as the total number of slits per total length of the
curve along with the glomerular hemodynamic measure-peripheral capillary basement membrane captured on
ments using a log-normal pore-size model of the glomer-the photomicrographs [23].
ular capillary wall. Assuming that both groups had a
Statistical analysis similar transglomerular hydraulic pressure (P) of 40
mm Hg [24], the mean radius of the glomerular poreResults are expressed as mean standard error of the
size distribution (u) was increased in renal allograft re-mean (SEM), unless indicated otherwise. Comparisons
cipients by about 3 A˚, on average, as compared to uni-between the groups were made by the unpaired Student
nephrectomy controls (46 2 vs. 43 2 A˚, respectively,t test. Differences between groups were considered sig-
P  0.05); the spread of the pore-size distribution (s)nificant if P  0.05.
was not different between the two groups (Table 3). A
shift to a larger size in the glomerular pore-size distribu-
RESULTS tion (Fig. 2) resulted in an enhanced prominence of the
Renal transplant recipients and donors who were one larger pores, reflected by the increase in the computed
parameters r*5% and r*1% in renal allografts versusto three years post-transplantation or kidney donation
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Table 1. Clinical parameters
Previous
Years after Serum rejection HTN
Agea Gender surgery creatinine Weight BMI CsA
years M/F range mg/dL kg kg/m2 number of patients ng/mL
Cadaveric renal 51 12/9 2.40.2b 1.20.1 784b 281 5 18b 19917
allograft recipients (21–72) (1–3)
Uninephrectomy 49 8/7 1.30.2 1.20.1 865 292 NA 0 NA
donor controls (29–71) (1–3)
Abbreviations are HTH: hypertension, defined as requirement for antihypertensive treatment; CsA, whole blood trough cyclosporine A level; NA, not applicable;
BMI, body mass index.
a Median (range)
b P  0.05 vs. uninephrectomy controls
Table 2. Glomerular function
Plasma oncotic
MAP pressure GFR RPF AERa IgG ERa
mm Hg mL/min/1.73 m2 FF lg/min
Cadaveric renal
allograft recipients 1033b 261 623 34326 0.190.01 9 (3–22) 2 (1–5)
Uninephrectomy
donor controls 943 261 634 33222 0.190.01 10 (1–78) 2 (1–3)
Abbreviations are: MAP, mean arterial pressure; GFR, glomerular filtration rate; RPF, renal perfusion flow; FF, filtration fraction; AER, albumin excretion rate;
IgG ER, IgG excretion rate.
a Median (range)
b P  0.05 vs uninephrectomy controls
could be transmitted to the glomerular capillaries, we
also calculated the membrane parameters assuming that
glomerular hypertension were present in renal allograft
recipients (P of 45 mm Hg) [25]. The results, shown in
Table 3, indicate the assumption that a difference in
the prevailing intraglomerular pressures had a negligible
effect on the calculated membrane parameters u and s.
As indicated in Table 3 and according to Equation 1,
if intraglomerular hypertension occurred in the renal
allografts, the ultrafiltration coefficient would be lower
to achieve the measured glomerular hemodynamics (Ta-
ble 2) in renal allograft recipients.
To determine whether the measured change in glo-
merular permeability was associated with ultrastructural
alterations, we performed a renal morphometric analysis
(Table 4). In renal allograft recipients one to three years
after transplantation, the prevalence of glomerular scle-
rosis was low (3  2%) and not statistically different
from that present in cadaveric kidneys at the time the
Fig. 1. Dextran sieving curve in renal transplant recipients () as com- kidney was transplanted (8  3%). Similarly, there was
pared to kidney donor controls () (*P  0.05 vs. controls).
no difference in the volume density of the mesangium
(VvM) or the mesangial volume between renal allografts
and biopsy controls. Notably, the glomerular volume was
not different between renal allografts one to three yearsuninephrectomy controls (72  1 vs. 67  1, and 82 
1 vs. 76  1 A˚, respectively, P  0.05; Table 3). There post-transplantation and two-kidney biopsy controls, but
the capillary filtration surface density (Sv) was higher inwere no differences in the one-kidney ultrafiltration coef-
ficient (Kf) between the two groups. Since the renal allo- renal allografts than in controls (P  0.05), resulting in
a higher capillary filtration surface area in renal allograftsgraft recipients had a higher systemic mean arterial pres-
sure than the kidney donor controls that potentially than in two-kidney controls (P  0.05). This increase in
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Table 3. Glomerular filtration barrier and membrane parameters
Ultrafiltration Mean glomerular Spread of
r*5% r*1%Assumed P coefficient, Kf pore size distribution
mm Hg units l s A˚ v2
Cadaveric 35 17.12.1 462a 1.210.01 721a 821a 0.51
renal allograft 40 7.71.2 462a 1.210.01 721a 821a 0.50
recipients 45 5.40.7a 472a 1.200.01 721a 821a 0.61
Uninephrectomy
donor controls 40 8.10.8 432 1.210.02 671 761 0.85
a P  0.05 vs controls
DISCUSSION
The overall glomerular function (GFR, RPF, FF and
plasma oncotic pressure) was almost identical in renal
allograft recipients and single-kidney controls, indicating
there were similar adaptations to the single-kidney state
over a comparable period of time. However, the dextran
sieving curve was strikingly different in the two groups:
the fractional dextran clearances in renal allograft recipi-
ents were uniformly elevated over the entire range of
molecular radii tested (28 to 66 A˚), and reached statisti-
cal significance for dextrans sized 38 to 66 A˚. Modeling
of glomerular function indicated that the increase in per-
meability was due to a shift to of the distribution of
glomerular pores to a larger size. The changes in glomer-
ular dextran permeability were associated with alter-
ations in glomerular capillary wall structure, even though
there was no evidence of significant global sclerosis or
mesangial expansion.Fig. 2. Distribution of filtrate volume permeating discrete glomerular
Our hypothesis was that differences in intraglomerularpores in renal transplant recipients (thick line) and in kidney donor
controls (thin line). hemodynamics and/or glomerular capillary wall function
will indicate early glomerular injury in the cadaveric
recipients, even when overall kidney function is un-
impaired (that is, no reduction in GFR or increase in
the glomerular capillary filtration surface density and proteinuria). The absolute levels of GFR were approxi-
area we found in renal allograft recipients could result mately 25% higher than the one-kidney values from
from an increase in the length and/or the diameter of the healthy individuals we previously reported [25], and
there was a parallel increase in RPF, so that the filtrationglomerular capillaries. The results of our morphometric
fraction was identical in both groups (Table 2). Sinceanalysis indicate (Table 5) that the higher glomerular
the plasma oncotic pressure also was identical, it followsfiltration area results from an increase in the mean glo-
that there were no differences in the average intraglo-merular capillary diameter, and not from a change in
merular oncotic pressure between the groups. In contrastcapillary length. Other structural alterations at the glo-
to the similarities in glomerular hemodynamics, the dex-merular capillary wall level were found (Table 4), where
tran sieving technique revealed a significant differencethe glomerular membrane was thicker in renal allografts
between cadaveric renal allograft and uninephrectomythan in controls (614  33 vs. 427  22 nm, respectively;
controls. Based on the log normal model of the glomeru-
P  0.05), but the number of epithelial filtration slits lar capillary wall of Deen et al, we computed that there
per peripheral capillary length was not different between was an increase in the mean pore size of the distribution
the groups. Despite the normal overall glomerular func- (u) by about 3 to 4 A˚, with no significant increase in the
tion in cadaveric recipients, the fractional cortical inter- standard deviation of the distribution(s). These changes
stitial area was also higher in renal allografts one to in pore distribution resulted in a shift to the right in the
three years after transplantation than in control biopsies distribution of filtrate volume permeating discrete pores,
obtained at the time of transplantation (19  3 vs. 12  and an enhanced passage of filtrate through the larger
pores of the distribution (Fig. 2). Such changes in mem-1% in controls, P  0.05, Table 4).
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Table 4. Renal morphometric analysis
Capillary Mesangial
VG filtering area volume BMT FSF Interstitial
10 6 lm2 GS % Sv S, 10 3 lm2 VvM 10 3 lm3 nm slits/mm PCL area %
Renal allograft
recipients 2.70.2 32 0.190.03a 51074a 0.140.01 39950 61433a 133948 193a
Biopsy controls
(2-kidney) 2.60.2 83 0.120.01 30231 0.160.01 43249 42722 121777 121
Abbreviations are: VG; volume of open glomeruli; GS, global sclerosis; Sv, glomerular capillary filtering density; VvM, volume density of mesangium; BMT,
glomerular basement membrane thickness; FSF, filtration slit frequency; PCL, peripheral capillary length.
a P  0.05 vs controls
Table 5. Morphometric analysis of glomerular capillaries
Capillary Average capillary Capillary
Capillary length length/glomerulus diameter Capillary volume/glomerulus
density (Lv) l 10 3 lm volume density l3 10 6
Renal allograft
recipients 0.00750.001 21.11.7 18.20.6a 0.4730.013a 1.340.12a
Biopsy controls
(2-kidney) 0.00770.001 20.42.3 16.20.5 0.3880.015 1.020.11
a P  0.05 vs. controls
brane permeability should result in increased trafficking distribution towards larger sizes, as observed in the pres-
ent study, but the change in the glomerular pore sizeof macromolecules and enhanced passage of large pro-
teins. However, these early changes were not accompa- distribution in patients with chronic transplant nephrop-
athy was of a greater magnitude than in our populationnied by increased albumin and IgG excretion rates in
final urine (Table 2). Under conditions of relatively low with preserved renal function. Thus, a continuum of in-
jury to the glomerular capillary could occur in the trans-filtered protein loads, the tubules could reabsorb most
of the filtered proteins so that they are not excreted in planted kidney, such that initially it may not be apparent
clinically, but as the injury progresses, it becomes clini-final urine in excessive amounts. For instance, Tucker,
Rasch and Blantz demonstrated that in rats with early cally evident by proteinuria and renal insufficiency. The
present study found alterations in the glomerular base-diabetes and no albuminuria, high albumin excretion
rates can be found in final urine when tubular albumin ment membrane similar to—but of a lesser magnitude
than—those described in patients with chronic transplantreabsorption is blocked with lysine [35], whereas in con-
trol rats lysine did not increase albuminuria. This sug- glomerulopathy, namely thickening and widening of the
glomerular basement membrane [37].gests that early loss of glomerular permselectivity and
enhanced transglomerular passage of proteins can be What could account for these findings? In contrast to
uninephrectomy controls, cadaveric renal allograft recip-masked by tubular protein reabsorption. Similarly, in
Pima Indians with early diabetes, Myers et al found an ients were taking several vasoactive drugs (ACE inhibi-
tors, calcium channel blockers and CsA), alone or inincrease in glomerular permeability to macromolecules
and dextrans with no significant increase in albumin ex- combination, which could affect glomerular function and
dextran sieving. ACE inhibitors acutely lower the filtra-cretion rates [36].
Are these changes predictive of late graft loss? There tion fraction in uninephrectomized healthy individuals
[38], but this should lower rather than increase the dex-have been no longitudinal studies of glomerular function
and dextran sieving in renal allograft recipients, so that tran sieving curve [31]. Moreover, in renal allograft recip-
ients with proteinuria, ACE inhibitors cause a trend tothe significance of these findings as early predictors of
late graft failure cannot be fully ascertained at this time. a lower filtration fraction and a generalized depression
of the dextran sieving curve [39], again, the opposite ef-However, in a group of patients with chronic transplant
nephropathy who had renal insufficiency and proteinuria fect of what we observed. The main renal hemodynamic
effect of the dihydropyridine calcium channel blockersand were studied with similar techniques, Mayer et al
found a generalized increase in dextran sieving curve is to increase renal blood flow [40], an effect that should
lower rather than increase the dextran sieving curve [31].versus healthy controls; the increase in fractional clear-
ance was more pronounced for dextrans (54 A˚) [13]. Cyclosporine A acutely reduces renal blood flow by
constricting the afferent arteriole, lowers GFR and in-This resulted from a shift in the glomerular pore size
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creases the filtration fraction [41]. These effects could diameter increases in the remnant kidney by 26, 12 and
14%, respectively [46]. Unfortunately, no such studiesreduce intraglomerular pressure, and because of its dif-
ferential effect on convective and diffuse fluxes, raise have been performed in humans. Therefore, it is possible
that renal allografts could have relative intraglomerularthe dextran sieving curve [42]. We think that a reduction
in P is unlikely to occur in renal transplant recipients hypertension versus uninephrectomized kidney donors
and a shift in the glomerular pore size distribution to afor the following reasons: (1) renal blood flow, GFR
and filtration fraction were identical in the two groups, larger size.
The glomerular ultrastructural alterations that followarguing against an acute hemodynamic effect; (2) most
patients were receiving dihydropyridine calcium channel the removal of 50% of kidney mass have not been well
characterized in humans. In an autopsy study, Narkum-blockers, agents that have been shown to counteract the
acute hemodynamic effects of cyclosporine [43]; and (3) Burgess et al did not find a significant increase in glomer-
ular volume in World War II veterans with a solitarya reduction in P would have to be associated with a
increase in Kf to maintain GFR (Eq. 1). For instance, kidney after uninephrectomy [19]. Glomerular hypertro-
phy also was not present in renal allografts with pre-calculating a 5 mm Hg reduction in P in transplant
recipients (from 40 to 35 mm Hg) would require a dou- served function as compared to two-kidney controls [47].
Unfortunately, lack of tissue preservation in these post-bling of the glomerular ultrafiltration coefficient versus
single kidney controls to maintain GFR (Table 3), a mortem specimens precluded a more detail analysis of
glomerular substructures in those studies. In keepingchange unlikely to be present only in the renal allografts
recipients. Finally, we performed a sensitivity analysis with these observations, we did not find glomerular hy-
pertrophy in well-functioning renal allografts as com-to determine whether changes in P could reproduce
the observed sieving curve in renal transplant recipients, pared to biopsies from two-kidney controls (Table 4). On
the other hand, the density of the glomerular capillaryassuming that the latter group had the same membrane
parameters (u and s) as the kidney donor controls. The filtering surface (Sv) was increased in renal transplant
recipients as compared to two-kidney controls, resultingresults (data not shown) indicate that changes in P
without changes in the glomerular pore size distribution in a larger total one-kidney capillary filtering area. This
finding suggests that the renal allografts had undergonecannot explain the observed dextran sieving curve. A
reduction inP to 35 mm Hg would elevate the fractional structural adaptations to the single kidney state. Also,
the increase in capillary filtering area in renal allograftsclearance of 28 to 34 A˚ size dextrans (a region of the
sieving curve that is not statistically different from donor resulted from an increase in the mean diameter of the
glomerular capillaries, rather than increases in capillarycontrols, Fig. 1), but it would have no effect on the
fractional clearance of dextrans in the 38 to 66 A˚ range, length. Interestingly, the glomerular adaptive changes
were restricted to the capillary compartment, since therethe region of the curve which is significantly different
from controls. Taken together, we conclude that neither were no differences in the mesangial density or total
mesangial area between the two groups (Table 4). How-cyclosporine A nor other vasoactive medications taken
by the renal transplant recipients could account for the ever, at the glomerular capillary wall level (the structural
barrier to macromolecular filtration), renal allografts hadobserved increase in fractional dextran clearance.
A generalized increase in the dextran sieving curve a thickened glomerular basement membrane, with no
change in the number of epithelial filtration slits per unithas been induced experimentally in humans by infusing
angiotensin II at doses that cause a slight (4 mm Hg) of capillary length. This early increase in glomerular
basement membrane thickness may be important, be-increase in systemic mean arterial pressure. There also
is a 1 to 2 A˚ increase in the size of the main glomerular cause we have found that the thickness of the glomerular
basement membrane is increased further in patients withpores. However, in contrast to our study, angiotensin
infusion markedly reduces renal blood flow and increases chronic transplant nephropathy who had renal insuffi-
ciency (unpublished observations), suggesting that earlythe filtration fraction [44]. In the rat, angiotensin II can
enhance dextran permeability, which could be mediated structural alterations may be involved in the mechanisms
of progressive renal insufficiency in renal allografts. Forby “stretch”-induced changes in membrane porosity,
probably mediated by increases in the glomerular hy- example, a thickened glomerular basement membrane
could increase the resistance to water flow across thedraulic pressure and P [45]. It is worth noting that
transplant recipients had a higher systemic mean arterial glomerular capillaries and lower the hydraulic glomeru-
lar membrane conductivity. Early increases in basementpressure than their uninephrectomy controls. This could
be transmitted to the glomerular capillaries, elevate the wall thickening could be offset by increases in the total
glomerular filtering area, so that Kf, the product of theintraglomerular hydraulic pressure and change the pore
size distribution to a larger size by stretch-mediated hydraulic membrane conductivity and total filtering area,
would be unchanged. Unfortunately, there are no pub-mechanisms. It is worth noting that in uninephrectom-
ized adult rats, glomerular capillary number, length and lished studies of glomerular capillary ultrastructure in
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323, 1992
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adaptations to the single kidney state differ between shared, HLA-matched kidney transplants from cadaveric donors.
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